Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
24.4%
% of GNOM's 41 holdings also in IDNA
23.8%
% of IDNA's 46 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
CRISPR THERAPEUTICS AG | 5.8% | 4.6% | 4.6% |
|
BEAM THERAPEUTICS, INC. | 3.6% | 4.2% | 3.6% |
 |
BIONTECH SE SPONSORED ADR | 3.3% | 4.4% | 3.3% |
|
MODERNA, INC. | 3.3% | 2.9% | 2.9% |
|
INTELLIA THERAPEUTICS, INC. | 4.0% | 2.2% | 2.2% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to IDNA
 |
ENI SPA-SPONSORED ADR | 7.5% |
|
NATERA INC | 4.4% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.9% |
|
AGILENT TECHNOLOGIES INC | 3.9% |
|
10X GENOMICS INC CLASS A | 3.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | 3.8% |
 |
GENSCRIPT BIOTECH CORPORATION | 3.7% |
|
PACIFIC BIOSCIENCES OF CALIF | 3.7% |
|
QIAGEN NV | 3.6% |
|
BIOMARIN PHARMACEUTICAL INC | 3.5% |
GNOM Underweight Relative to IDNA
|
BLUEPRINT MEDICINES CORP. | -5.6% |
|
EXELIXIS INC | -5.4% |
|
REGENERON PHARMACEUTICALS | -5.2% |
 |
SANOFI-AVENTIS | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
|
TWIST BIOSCIENCE CORP. | -4.1% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -4.1% |
 |
ROCHE HOLDING LTD | -4.0% |
 |
BEIGENE, LTD. | -3.9% |
 |
GENMAB A/S | -3.9% |